News
Reeling from an FDA rejection, Telesta sheds 15% of its staff By Damian Garde Mar 9, 2016 9:29am Biotech Telesta CEO Michael Berendt ...
Ipsen has picked up the rights to Telesta Therapeutics' bladder cancer drug in Europe and other ex-U.S. markets in a deal worth up to $137 million (€124 million). Having acquired the rights for ...
By Reuters October 25, 20163:50 PM UTCUpdated ago Oct 25 (Reuters) - Telesta Therapeutics Inc : * Telesta Therapeutics Inc. shareholders approve plan of arrangement with Prometic Life Sciences Inc.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback